亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Redefining Relative Biological Effectiveness in the Context of the EQDX Formalism: Implications for Alpha-Particle Emitter Therapy

相对生物效应 剂量学 α粒子 核医学 背景(考古学) 放射治疗 放射生物学 吸收剂量 辐射 物理 医学物理学 外照射放疗 线性能量转移 核工程 医学 近距离放射治疗 核物理学 放射科 生物 工程类 古生物学
作者
Robert F. Hobbs,Roger W. Howell,Song Hong,Sébastien Baechler,George Sgouros
出处
期刊:Radiation Research [Radiation Research Society]
卷期号:181 (1): 90-98 被引量:48
标识
DOI:10.1667/rr13483.1
摘要

Alpha-particle radiopharmaceutical therapy (αRPT) is currently enjoying increasing attention as a viable alternative to chemotherapy for targeting of disseminated micrometastatic disease. In theory, αRPT can be personalized through pre-therapeutic imaging and dosimetry. However, in practice, given the particularities of α-particle emissions, a dosimetric methodology that accurately predicts the thresholds for organ toxicity has not been reported. This is in part due to the fact that the biological effects caused by α-particle radiation differ markedly from the effects caused by traditional external beam (photon or electron) radiation or β-particle emitting radiopharmaceuticals. The concept of relative biological effectiveness (RBE) is used to quantify the ratio of absorbed doses required to achieve a given biological response with alpha particles versus a reference radiation (typically a beta emitter or external beam radiation). However, as conventionally defined, the RBE varies as a function of absorbed dose and therefore a single RBE value is limited in its utility because it cannot be used to predict response over a wide range of absorbed doses. Therefore, efforts are underway to standardize bioeffect modeling for different fractionation schemes and dose rates for both nuclear medicine and external beam radiotherapy. Given the preponderant use of external beams of radiation compared to nuclear medicine in cancer therapy, the more clinically relevant quantity, the 2 Gy equieffective dose, EQD2(α/β), has recently been proposed by the ICRU. In concert with EQD2(α/β), we introduce a new, redefined RBE quantity, named RBE2(α/β), as the ratio of the two linear coefficients that characterize the α particle absorbed dose-response curve and the low-LET megavoltage photon 2 Gy fraction equieffective dose-response curve. The theoretical framework for the proposed new formalism is presented along with its application to experimental data obtained from irradiation of a breast cancer cell line. Radiobiological parameters are obtained using the linear quadratic model to fit cell survival data for MDA-MB-231 human breast cancer cells that were irradiated with either α particles or a single fraction of low-LET (137)Cs γ rays. From these, the linear coefficient for both the biologically effective dose (BED) and the EQD2(α/β) response lines were derived for fractionated irradiation. The standard RBE calculation, using the traditional single fraction reference radiation, gave RBE values that ranged from 2.4 for a surviving fraction of 0.82-6.0 for a surviving fraction of 0.02, while the dose-independent RBE2(4.6) value was 4.5 for all surviving fraction values. Furthermore, bioeffect modeling with RBE2(α/β) and EQD2(α/β) demonstrated the capacity to predict the surviving fraction of cells irradiated with acute and fractionated low-LET radiation, α particles and chronic exponentially decreasing dose rates of low-LET radiation. RBE2(α/β) is independent of absorbed dose for α-particle emitters and it provides a more logical framework for data reporting and conversion to equieffective dose than the conventional dose-dependent definition of RBE. Moreover, it provides a much needed foundation for the ongoing development of an α-particle dosimetry paradigm and will facilitate the use of tolerance dose data available from external beam radiation therapy, thereby helping to develop αRPT as a single modality as well as for combination therapies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
学而时习芝士蛋糕完成签到,获得积分10
1秒前
zhaodan完成签到,获得积分10
4秒前
8秒前
Alice发布了新的文献求助10
13秒前
guyuzheng完成签到,获得积分10
14秒前
ZZWZHENG发布了新的文献求助50
19秒前
爱听歌谷蓝完成签到,获得积分10
20秒前
魔幻的芳完成签到,获得积分10
27秒前
Rosemary绛绛完成签到 ,获得积分10
28秒前
悲凉的忆南完成签到,获得积分10
33秒前
科研通AI6.3的应助被qingsyxuan采纳,获得10
38秒前
陈旧完成签到,获得积分10
40秒前
奔跑的应助被科研通管家采纳,获得10
45秒前
欣欣子完成签到,获得积分10
46秒前
瘦瘦的广缘完成签到,获得积分10
49秒前
yxl完成签到,获得积分10
53秒前
58秒前
可耐的盈完成签到,获得积分10
59秒前
1分钟前
杰西咔发布了新的文献求助10
1分钟前
绿毛水怪完成签到,获得积分10
1分钟前
3sigma完成签到,获得积分10
1分钟前
完美一德发布了新的文献求助10
1分钟前
1分钟前
牵着蜗牛散步完成签到 ,获得积分10
1分钟前
苹果元灵完成签到,获得积分10
1分钟前
lsc完成签到,获得积分10
1分钟前
完美一德完成签到,获得积分10
1分钟前
小fei完成签到,获得积分10
1分钟前
Alice给Alice的求助进行了留言
1分钟前
麻辣薯条完成签到,获得积分10
1分钟前
1分钟前
风不言喻完成签到,获得积分10
1分钟前
时尚身影完成签到,获得积分10
1分钟前
邓润杰发布了新的文献求助20
1分钟前
leoduo完成签到,获得积分0
1分钟前
流苏2完成签到,获得积分10
1分钟前
1分钟前
迅速的怀曼完成签到,获得积分10
1分钟前
勤劳寒松完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173030
求助须知:如何正确求助?哪些是违规求助? 9565519
关于积分的说明 21780317
捐赠科研通 7765028
什么是DOI,文献DOI怎么找? 3431521
关于科研通互助平台的介绍 2555605
邀请新用户注册赠送积分活动 2476658